id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S12619 R47576 |
Van Marter (Levetiracetam) (Controls unexposed, disease free), 2021 | Prematurity - Extreme (<28 wk gestational age) | at least 1st trimester | prospective cohort | unexposed, disease free excluded | Adjustment: No |
1.09 [0.07;17.73] C excluded (control group) |
1/97 1/106 | 2 | 97 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S12616 R47558 |
Van Marter (Levetiracetam) (Controls unexposed, sick), 2021 | Prematurity - Extreme (<28 wk gestational age) | at least 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 0.46 [0.02;11.72] C | 1/97 0/15 | 1 | 97 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S7807 R23105 |
Coste (Levetiracetam) (Controls unexposed, NOS), 2020 | Gestational age at birth (22-26 WA) | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No | 1.35 [0.19;9.60] C | 1/621 2,041/1,710,441 | 2,042 | 621 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 2 studies | 1.01 [0.19;5.41] | 2,043 | 718 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Levetiracetam) (Controls unexposed, sick; 2: Levetiracetam) (Controls unexposed, NOS;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 12619